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Abstract 
Pelizaeus-Merzbacher disease (PMD) results from an X-linked misexpression of proteolipid 
protein 1 (PLP1). This leukodystrophy causes severe hypomyelination with progressive 
inflammation, leading to neurological dysfunctions and shortened life expectancy. While no 
cure exist for PMD, experimental cell-based therapy in the dysmyelinated shiverer model 
suggested that human oligodendrocyte progenitor cells (hOPCs) or human neural precursor 
cells (hNPCs) are promising candidates to treat myelinopathies. However, the fate and 
restorative advantages of human NPCs/OPCs in a relevant model of PMD has not yet been 
addressed. Using a model of Plp1 overexpression, resulting in demyelination with progressive 
inflammation, we compared side-by-side the therapeutic benefits of intracerebrally grafted 
hNPCs and hOPCs. Our findings reveal equal integration of the donor cells within 
presumptive white matter tracks. While the onset of exogenous remyelination was earlier in 
hOPCs-grafted mice than in hNPC-grafted mice, extended lifespan occurred only in hNPCs-
grafted animals. This improved survival was correlated with reduced neuroinflammation 
(microglial and astrocytosis loads) and microglia polarization towards M2-like phenotype 
followed by remyelination. Thus modulation of neuroinflammation combined with myelin 
restoration is crucial to prevent PMD pathology progression and ensure successful rescue of 
PMD mice. These findings should help to design novel therapeutic strategies combining 
immunomodulation and stem/progenitor cell-based therapy for disorders associating 
hypomyelination with inflammation as observed in PMD. 
Introduction 
Pelizaeus-Merzbacher disease (PMD) results from proteolipid protein 1 (PLP1) gene 
mutations. It is a rare hypomyelinating leukodystrophy characterized by delayed motor and 
cognitive development, nystagmus, ataxia, hypotonia, and spasticity in the first year of life. 
The severity and onset of this X-linked recessive degenerative central nervous system (CNS) 
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disorder depends upon the nature of PLP1 mutations, which include duplication and point 
mutations. Changes in expression of myelin proteins are associated with progressive 
hypertrophic astrogliosis and massive microglial activation in animal models of PMD [1-3] 
and in man [4, 5]. Interestingly, microglia/macrophage activation varies with disease severity 
in PMD patients and PLP1 mutant mice, indicating that the inflammatory response to PLP1 
gene mutations is conserved among species [5]. Complete PLP1 gene duplication (62%) [6] is 
the most common cause of PMD and leads to marked CNS hypomyelination. This mutation 
increases PLP1 gene dosage [7] primarily causing toxic PLP1 accumulation in 
oligodendrocyte endoplasmic reticulum [8], leading to microglial activation and 
oligodendrocyte death [9]. As PLP1 is fully conserved between mouse and human and no 
spontaneous duplication of Plp1 exists in animal models, several transgenic mice 
overexpressing Plp1 were generated to decipher PMD pathohysiology [7, 10]. The transgenic 
Plp-tg line #66, exhibiting a 2-fold transcriptional overexpression of Plp1, is the most relevant 
model of PMD with Plp1 duplication [11]. Mice phenotype includes severe hypomyelination, 
progressive astrocytosis and microglial activation, seizures, motor and sensory deficits and a 
shortened lifespan [7], as in PMD patients [5, 12]. 
While there is currently no cure for PMD, transplantation of neural precursor cells (NPCs) or 
oligodendrocyte progenitor cells (OPCs) has emerged as a promising approach to replace 
affected oligodendrocytes. Indeed, successful myelination was achieved after engraftment of 
human NPCs [13, 14] and OPCs [15, 16] derived from fetal brain or differentiated from 
induced pluripotent stem cells (iPS) [17] in the immunodeficient dysmyelinated shiverer 
model. Extended lifespan of shiverer mice has been reported after transplantation with hOPCs 
[18] but not with hNPCs, suggesting that hOPCs might be the best cell candidate to treat 
myelin disorders such as PMD [15, 19, 20]. On the other hand, NPCs could have an 
advantage compared to OPCs in diseases associating demyelination and inflammation like 
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PMD. Indeed, NPCs that release multiple neurotrophins and cytokines, have been shown to 
attenuate brain inflammation after delivery in inflammatory models of multiple sclerosis [21-
24], and to decrease classically activated (M1-like) macrophages in severely contused spinal 
cord [25]. Although shiverer mice, due to their MBP deficiency, are an excellent model 
system to trace donor-derived myelin, these mice are not representative of PMD since they do 
not display mutations in the Plp1 gene, nor do they reflect the noxious inflammatory 
component of PMD [3, 5, 26]. To date the therapeutic benefits of hNPCs and/or hOPCs after 
transplantation in a relevant model of PMD, such as Plp1 duplication, characterized by 
demyelination and progressive inflammation, is still lacking. Understanding the therapeutic 
impact of each cell type when facing such noxious environment would foster successful 
translation of stem cell-based therapy from bench to clinic. 
In this study, we took advantage of the Plp-tg line #66 that faithfully mimics PMD 
duplication. We crossed Plp-tg mice over the Rag null background (Plp-tg:Rag) to prevent 
rejection of the human donor cells and compared in parallel the therapeutic benefits of 
intracerebrally grafted hNPCs and hOPCs. We report that upon transplantation in the neonate 
immunodeficient Plp1 overexpressing mice, both cell types integrated equally well in the 
PMD environment. While each cell type functionally replaced the host deficient 
oligodendrocytes within the time-frame corresponding to their differentiation stage, only 
hNPCs rescued the severely affected PMD mice. The impressive therapeutic benefit of hNPCs 
was directly correlated with their ability to modulate inflammation prior to remyelination. 
These data indicate that inflammatory modulation is a pre-requisite to myelin restoration to 
promote survival and clinical recovery of PMD mice. They also suggest promising 
perspectives of combining immunomodulation and stem/progenitor cell-based therapy for 
myelin disorders associating hypomyelination with inflammation.  
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Materials and Methods 
Mouse line 
Plp-tg mice (mouse line #66), overexpressing Plp1 genes resulted from the autosomal 
insertion of a transgene comprising seven copies of the wild type murine Plp1 gene [7]. To 
avoid cell rejection, homozygous Plp-tg mice were crossed to homozygous recombination 
activating gene-2 null immunodeficient mice to generate Plp-tg:Rag mice (tg66/tg66 x Rag2-/-
). Shiverer:Rag2-/- mice were used in this study to confirm the timing of myelination by the 
different transplanted cells. These mice were generously provided by S. Goldman’s laboratory 
[16]. 
 
hNPCs culture 
Human foetuses were obtained after legal abortion according to the recommendations of the 
Agence de la Biomedecine (agreement #003187) with the written consent of the patients. 
hNPCs were isolated from lateral ganglionic eminences of human foetuses (7 to 9 weeks of 
gestation) as previously described [13]. They were amplified in spheres in N medium 
(consisting of a 1:1 mixture of Dulbecco’s modified Eagle’s medium-F12 supplemented with 
1% N2 supplement; 0.5% B27; 5 mM HEPES (all Life technologies); 20 ng/ml insulin 
(Eurogenetec); 6 mg/ml glucose (Sigma) supplemented with 20 ng/ml basic fibroblast growth 
factor and 20 ng/ml epidermal growth factor (Peprotech). 
 
CMV-GFP transduction of hNPCs 
For their traceability after transplantation, hNPCs were transduced with the cytomegalovirus-
green fluorescent protein (CMV-GFP) lentiviral vector at an MOI of 1.1. Efficiency of 
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transduction (>90%) was determined on fixed cells by immunocytochemistry using a chicken 
anti-GFP antibody at (1:500, Aves, GFP-1020). 
 
hOPCs production and CD140a/PDGFRα cell sorting 
To generate hOPCs, hNPCs were induced to differentiate after seeding onto 
polyornithine/laminin-coated dishes, and feeding during 3 weeks with N medium, 
supplemented with PDGF-AA (10 ng/ml) (Sigma-Aldrich), bFGF and EGF (20 ng/ml). 
Medium was changed every 2-3 days. Flow cytometry of hOPCs-derived hNPCs was 
performed with a FACSAria III (Becton Dickinson) after cell dissociation using Accumax 
(Sigma) and 30 minutes incubation on ice with the following antibodies: mouse anti-human 
CD140a-PE-conjugated antibodies (1:50, BD, 556001), and mouse anti-human IgG2a-PE-
conjugated (1:50, BD, 554648). This procedure allowed the selection of 17.2 ± 1.2% of 
CD140a/PDGFRα+ cells in 6 independent experiments. After sorting, cells were washed and 
either processed for RNA extraction, plated for immunocytochemical characterization or 
directly resuspended at 105 cells per µl into DMEM medium for transplantation. 
 
Isolation of CD11+ cell from corpus callosum of Plp-tg:Rag mice 
Fifteen week old Plp-tg:Rag mice (n=4) of each group (hNPCs-grafted, hOPCs-grafted and 
ungrafted) were anesthetized with pentobarbital (50mg/kg) and then sacrificed by transcardiac 
perfusion with PBS 1X. Corpora callosa were isolated and dissociated using the “neural tissue 
dissociation kit (P)” (Miltenyi) in combination with the gentleMACS Dissociator. In order to 
significantly improve CD11b staining of the resulting single-cell suspensions, myelin debris 
were removed according to “myelin removal beads II” instructions (Myltenyi). Finally, 
CD11b+ cells were magnetically labeled with “CD11b MicroBeads” (Miltenyi) and harvested 
on the MACS Separator. 
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RNA Extraction and Real-Time RT-PCR 
Total RNA from unsorted cells and CD140a resulting fractions were extracted according to 
the RNeasy Mini Protocol (Qiagen). Reverse transcription was performed with SuperScript III 
reverse transcriptase (Life technologies). Real-time PCR was performed with Light Cycler 
480 SYBR Green I Master (Roche) using the LightCycler® 480 System. The following 
primers were used for RT-PCR: Cyclophilin A forward (Fw) 5’-
CCCACCGTGTTCTTCGACAT-3’, Cyclophilin A reverse (Rev) 5’-
CCAGTGCTCAGAGCACGAAA-3’, PDGFRalpha Fw 5’-
TTGACAACCTCTACACCACACTGA-3’, PDGFRalpha Rev 5’-
TCCGGTACCCACTCTTGATCTTAT ; TuJI Fw 5’- GGCCTGACAATTTCATCTTTGG -
3’, TuJI Rev 5’-ACCACATCCAGGACCGAATC-3’, MAP5 Fw 5’-
CTGTGGAAAAGGCAGCAAAAC -3’, MAP5 Rev 5’- 
CAGCATTCTTGGTCTCCTTGTCT-3’. 
Primers used to quantify M1-like and M2-like gene xpression of CD11b+ cells, isolated from 
the corpora callosa of hNPCs / hOPCs-grafted and ungrafted (homozygous) Plp-tg:Rag mice, 
were designed according to Chhor et al., 2013 [27]. 
 
Primary microglial culture 
Primary mixed glial cell cultures were prepared from newborn C57BL/6 mouse brain. After 
removal of the meninges, cortices were dissociated and the resulting cell suspension was 
resuspended in Dulbecco’s modified Eagle’s medium supplemented with 10% foetal bovine 
serum (all Life Technologies). Microglial cells were isolated from this primary mixed glial 
culture on day 14 by shaking before plating at 20,000 cells / cm2. The following day, 
microglial cells were treated for 24h with IFNγ at 100 µg/mL or IL-4 at 50 µg/mL (R&D 
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Systems) to polarize microglia to a M1-like or a M2-like phenotype respectively. Cells were 
then lysed, RNAs extracted, and used as positive control for in vivo CD11b+ cell gene 
expression analysis. 
 
Transplantation 
At postnatal day 1, newborn pups were cryoanesthetized before bilateral injections (105 
cells/1 µl) rostral to the corpus callosum, 1 mm caudally, 1 mm laterally from bregma and at a 
depth of 1 mm.  
 
Immunohistochemistry 
For immunohistochemistry, mice were sacrificed by transcardiac perfusion-fixation with 4% 
paraformaldehyde. Brains were sectioned horizontally at 12 µm thickness with a cryostat 
(CM3050S; Leica). In vivo characterization of grafted cells was performed by 
immunostaining using the following antibodies: anti-human NOGO-A (1:100, Santa Cruz 
Biotechnology, sc-11030), anti-PDGFR alpha (1:100, Santa Cruz Biotechnology, sc-338)), 
anti-APC (CC1, 1:100, Calbiochem, OP80), anti-MBP (1:400, Chemicon, AB980), anti-Olig2 
(1:500, Chemicon, AB9610). Neuroinflammation was characterized by Iba1 (1:500, Wako, 
019-19741) and GFAP (1:500, Dako, Z0334) staining, nodes of Ranvier, by Caspr (1:1000, 
generous gift from E. Peles, Rehovot, Israel) and Neurofascin (1:350, Abcam) staining, 
neuronal lineage by TuJI (1:100, Sigma, T8660) staining and proliferation by Ki67 (1:100, 
Dako, m7240) staining. For MBP, NOGO-A and Iba1 staining, sections were pre-treated with 
ethanol. Secondary antibodies conjugated with FITC, TRITC (SouthernBiotech) or Alexa 
Fluor 647 (Life Technologies) were used respectively at 1:100 and 1:1000. Nuclei were 
stained with Dapi (1 µg/ml, Sigma-Aldrich) (1:1,000). Imaging was performed with a 
fluorescent Apotome microscope (Zeiss) and Slide scanner (Nanozoomer, Hamamatsu). 
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MRI 
T2-weighted MRI images were acquired using 11.7 T MRI (BioSpec 117/16, Brüker) on 
ungrafted Plp-tg:Rag mice at 15 weeks. Mice were anesthetized using a mixture of 
isofluorane (5% for induction 1 1.5% for maintenance) gas and air at a flow rate of 1 L/min 
via a face mask. Mouse breathing rate was monitored throughout the experiment and body 
temperature was maintained at 38°C using circulating water.  
 
Electron microscopy 
For phenotype characterization, ungrafted Plp-tg:Rag mice were sacrificed at 4 weeks by 
transcardiac perfusion with 4% paraformaldehyde/2.5% glutaraldehyde (Euromedex). Brains 
were cut into 70 µm-thick pieces and fixed in 2% osmium tetroxide (Sigma) overnight.  
For characterization of donor-derived myelin by immuno-electron microscopy, grafted 
animals were perfused with 4% paraformaldehyde and 0.025% glutaraldehyde (Electron 
Microscopy Science). Brains were removed and cut into 70 µm slices with a vibratome VT- 
1000S (Leica). For GFP immunodetection, slices were incubated overnight with anti-GFP 
(1:400, Nacalai Tesque, 04404-84) at 4°C, followed by 3 hours incubation at room 
temperature with biotin-conjugated anti-rat antibody (1:100, Jackson Beckman, 112-066-062), 
followed with streptavidin conjugated to beta-galactosidase (1:100, Vector, A-2300). Beta 
galactosidase was revealed by Bluo-Gal (Sigma) incubation for 3 hours at 37°C. 
Immunolabeled slices were then post-fixed with 2.5% glutaraldehyde for 2 h and 2% osmium 
tetroxide (Electron Microscopy Science) for 30 min. After dehydration, samples were 
embedded in epon. Ultra-thin sections were analyzed with a Hitachi HT7700 electron 
microscope. 
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Behavioural assays 
Global locomotor performances of grafted and ungrafted mice were evaluated using a rotarod 
(Letica, Barcelona, Spain) to measure coordination balance and motor control of hindlimbs. 
Tests were performed at 10, 15, 20 and 33 weeks post-grafting. Mice were placed on a 
rotating beam. The rod was set to accelerate from 4 to 40 revolutions per minute (rpm) over 
30s and then maintained a constant speed.  
 
Quantification analysis and statistical analysis 
For in vivo analysis of differentiation and inflammation, 3-4 sections per animal and 3-5 
animals per condition were analysed. Data collected with the Nanozoomer were analysed and 
quantified using the MorophoStrider software (Exploranova). The percentages of GFP+ cells 
expressing APC or NOGO-A were established over the total number of GFP+ cells. The 
extent of myelination or neuroinflammation corresponded to the MBP, GFAP or Iba1 labelled 
area divided by the whole corpus callosum area.  
All statistical comparisons included Student’s t test. The cut-off for statistical significance 
was set at *p < 0.05; **p<0.01; ***p<0.001. Statistical analysis was performed with Statistica 
software. Data are shown as mean ± standard error of the mean (SEM).  
 
Study approval 
All animal care and experiments conformed to European Community regulations and 
INSERM ethical committee (authorization 75-348; 20/04/2005).  
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Results  
Characterization of Plp-tg:Rag mice 
To prevent immune-rejection and facilitate analysis of transplanted human xenografts, Plp-
overexpressing mice (line #66) were crossed with the immunodeficient strain Rag2-/-. We first 
confirmed that the Rag2-/- phenotype did not alter the phenotype of the Plp-tg mice. Although 
myelination onsets after birth, widespread hypomyelination [7] was detected in all one month 
old homozygous Plp-tg:Rag brains as viewed by T2 weighted imaging (Fig. 1B) and 
confirmed by MBP immunolabeling (Fig. 1C, C’). Electron microscopy revealed very few 
myelinated axons (Fig. 1A). Immunohistochemistry for GFAP and Iba1 revealed astrogliosis 
(Fig. 1D, D’) and activated microglial cells (Fig. 1E, E’) confirming the strong inflammatory 
context in homozygous Plp-tg:Rag, even though T and B cells were absent. The preservation 
of these abnormalities was associated with seizures and premature death of the double 
transgenic mice around 20 weeks reflecting the original phenotype of the Plp-tg line. 
 
Characterization of hNPCs and hOPCs 
Human NPCs were isolated from lateral ganglionic eminences of three independent foetuses 
[13] and differentiated in vitro into hOPCs. We previously demonstrated after long-term in 
vitro amplification (100 days) that hNPCs conserved their immature state and their 
proliferative activity expressing, respectively, the neural stemness marker Nestin (98.5%) and 
proliferation marker Ki67 (42.6%), and only few differentiated cells expressing GFAP 
(5.6%), TuJ1 (2.1%), Olig2 (32.4%) and A2B5 (3.4%).. Moreover, these cells were 
multipotent after engraftment into the adult demyelinated nude spinal cord, and they 
successfully remyelinated the demyelinated adult shiverer spinal cord [13].  
To avoid heterogeneity among cell sources, hOPCs were derived from the in vitro 
differentiation of these hNPCs, in the presence of platelet-derived growth factor (PDGF). 
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After three weeks, cell cultures were specifically enriched in early hOPCs by fluorescence-
activated cell sorting (FACS) using the OPC specific cell marker, CD140a/PDGFRα [15]. 
Consequently, CD140a positive cell fractions were all positive for CD140a/PDGFRα. The 
majority expressed Ki67 (>80%) and Olig2 (>90%). Moreover they showed a typical OPC 
bipolar phenotype (Fig. 2A-C). In contrast, the CD140a negative fractions did not express 
PDGFRα or Olig2 but displayed a neuronal phenotype and expressed the immature neuronal 
marker TuJ1 (>90%) (Fig. 2D-F). Both fractions were devoid of GFAP+ cells (<0.01%). 
Quantitative RT-PCR confirmed enrichment of PDGFRα transcripts in the CD140a positive 
populations and of the neuronal Tuj1 and Map5 transcripts in the CD140a negative 
populations (Fig. 2G). 
To better define the CD140a+/PDGFRα+ sorted cells, we compared their myelinogenic 
potential to hNPCs after transplantation into newborn shiverer:Rag mice. In line with 
previous studies [15, 16], our results indicated faster myelinogenic capacity of hOPCs 
(CD140a+/PDGFRα+) since they produced extensive myelin 15 weeks post transplantation 
(p.t.) while hNPCs produced myelin only at later times (Fig. 2H-I). Moreover, hOPCs 
transplants increased shiverer:Rag mice survival up to 30 weeks whereas hNPCs transplants 
extended survival only up to 25 weeks (Fig. 2J).  
 
Grafted hNPCs improve Plp-tg:Rag mice lifespan and locomotion 
We next evaluated the therapeutic outcome of hNPCs and hOPCs in the PMD model. We first 
assessed the effects of both cell types on survival and locomotion after bilateral cell injections 
(105 cells/µl) rostrally to the corpus callosum of postnatal day 1 Plp-tg:Rag mice. 
Surprisingly, while hOPCs grafts improved shiverer:Rag survival, they did not prolong 
lifespan of Plp-tg:Rag mice, which died prematurely at 19.6 ± 1.3 weeks. In contrast, hNPCs 
transplants significantly increased Plp-tg:Rag mice life expectancy (32,5 ± 2.9 weeks, 
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p<0.001) compared to ungrafted mice (20.0 ± 0.6 weeks) (Fig. 3A-B). This value was 
strongly underestimated due to the multiple sacrifices performed to evaluate remyelination by 
MRI or electron microscopy after 25 weeks. 
Hypomyelination in Plp-tg:Rag mice results in progressive hind limb weakness and 
consequently locomotor defects. We therefore evaluated motor coordination and balance by 
rotarod assay. Ungrafted Plp-tg:Rag mice showed increased balance deficits with age since 
rod fall latencies decreased from 14.7 ± 1.2 sec at 10 weeks p.t. to 10.9 ± 1.0 sec at 30 weeks 
p.t. Performances of hNPCs-grafted mice tended to be improved compared to ungrafted Plp-
tg:Rag mice at every experimental time point (15.7 ± 1.0 sec at 10 weeks p.t. and 14.3 ± 1.5 
sec at 30 weeks p.t.), and were significantly higher at 25 weeks p.t. (16.1 ± 0.9 sec vs 12.5 ± 
0.9 sec). 
 
Long-term cell survival and widespread migration is achieved equally by grafted 
hNPCs and hOPCs in Plp-tg:Rag mice  
To decipher why hNPCs rescued Plp-tg:Rag mice in contrast to hOPCs, we first analysed 
survival and migratory potentials of the grafted cells. At 15 weeks p.t., both grafted cell types 
extensively invaded brain regions and more particularly the fimbria and the corpus callosum 
(Supplementary Data Fig. S1A). Evaluation of grafted cell density in the corpus callosum 
indicated that the percentage of integrated cells was similar for hNPCs (20.2 ± 3.3%) and 
hOPCs (27.4 ± 5.8%) (Supplementary Data Fig. S1B). Moreover, both grafted cell types were 
also found in other white matter structures such as cerebellum, striatum, anterior commissure 
or olfactory bulb, as illustrated for hNPCs (Supplementary Data Fig. S1C), highlighting their 
great capacity to migrate across the anterior-posterior and dorso-ventral axes from two rostral 
injection sites. Furthermore, both transplanted cell types had a great capacity to survive in the 
PMD environment since immunohistochemistry for Caspase 3 indicated low rates of cell 
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death (<0.01%) at 15 weeks p.t. Excellent survival of the grafted cells was further confirmed 
by the detection of substantial populations of hNPCs in Plp-tg:Rag mice that survived up to 
48 weeks p.t. 
 
Grafted hNPCs and hOPCs mature into oligodendrocytes at different rates 
We next assessed the capacity of grafted cells to differentiate into oligodendrocytes and 
generate functional myelin. At 15 weeks p.t., hOPCs had a mature morphology with multi-
branched processes while hNPCs remained essentially as immature bipolar cells (Fig. 4A). 
Most hOPCs expressed APC (76.5 ± 5.5%) and human NOGO-A (38.7 ± 10.5%), whereas 
only a few hNPCs expressed these markers (respectively 15.8 ± 4.7% and 2.1 ± 0.9%) (Fig. 
4A-C). However, in the hNPCs-grafted mice, which survived up to 30 weeks p.t., hNPCs 
generated similar proportions of APC+ (87.1 ± 2.3%) and NOGO-A+ (50.2 ± 5.3%) cells as 
hOPCs at 15 weeks p.t. (Fig. 4C), indicating their slower pace but equal capacity to 
differentiate into oligodendrocytes.  
 
Grafted hNPCs and hOPCs differentiate into functional oligodendrocytes 
Similarly, while myelin was detected in the majority of the structures colonized by grafted 
hOPCs at 15 weeks p.t., we only detected myelin-like debris in hNPCs-grafted mice, 
suggesting ongoing demyelination as observed in homozygous ungrafted mice (Fig. 5A). 
Consistent with their slower differentiation into mature oligodendrocytes, hNPCs achieved 
robust myelination only at 30 weeks p.t., with MBP+ area in the corpus callosum (76.6 ± 
19.7% of MBP+ area) reaching similar extension to the one detected at 15 weeks p.t in 
hOPCs-grafted animals (64.7 ± 11.1%) (Fig. 5B-C). As MBP+ myelin debris can persist in 
Plp-tg:Rag mice, we used multiple approaches to demonstrate that myelin was produced by 
the human grafted cells. First, orthogonal views of MBP+ interactions with GFP+ grafted cells 
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revealed multiple branched processes ending in T shape, a typical feature of myelin-forming 
oligodendrocytes [13] connecting host axons (Fig. 5D). The myelinating potential of 
transplanted cells was further investigated by immuno-electron microscopy at 48 weeks p.t. 
BluoGal precipitates, which reveal GFP staining, were restricted to myelin structures and 
were exclusively present in areas containing GFP+ cells prior to embedding. Therefore, 
detection of BluoGal precipitates by electron microscopy within myelin wrapping of host 
axons validated that myelin was donor derived (Fig. 5E). Higher magnification indicated that 
the donor-derived myelin was normally compacted. Finally, immunostaining for the 
paranodal protein Caspr and nodal Neurofascin revealed a higher density of nodes of Ranvier 
in areas of the corpus callosum containing GFP+ cells compared to areas lacking GFP+ cells or 
to ungrafted mice (Fig. 5F). Moreover, co-labeling for GFP and Caspr confirmed the donor 
origin of the paranodal structures (Fig. 5G). These data indicate nodal reconstitution by the 
gratfed cells and highlight the functionality of the donor-derived myelin. 
 
Only grafted hNPCs down-regulate inflammation in Plp-tg:Rag mice 
Despite their potential for efficient integration and myelination, hOPCs failed to improve the 
survival of Plp-tg:Rag mice. We therefore asked whether these two grafted cell populations 
might differentially modulate their host environment and in particular the inflammatory 
burden of Plp-tg:Rag mice. Indeed, PLP1 overexpression leads to increased astrocytosis and 
massive microglial activation, both associated with aggravated clinical symptoms. We 
explored microglial and astrocyte reactivity in Plp-tg:Rag mice by immunodetection of Iba1 
and GFAP respectively. Engraftment with hNPCs significantly reduced both microglial (Fig. 
6A) and astrocyte (Fig. 6B) loads in white matter areas in Plp-tg:Rag as compared to 
ungrafted mice. The percentages of the corpus callosum labelled for GFAP and Iba1 were 
49.1 ± 9.1% and 31.5 ± 2.4% respectively in ungrafted mice, 73.4 ± 17.4% and 39.0 ± 9.3% 
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in hOPC-grafted mice and 18.6 ± 5.3% and 7.8 ± 1.2% in hNPCs-grafted mice. These data 
indicate reductions in astrocyte and microglial loads of ~3-4 fold in hNPCs-grafted animals 
compared to ungrafted and hOPC-grafted mice.  
Different shapes and process ramifications of astrocytes and microglia in hOPCs- and hNPCs-
grafted mice, prompted us to define the activation state of microglial cells. Classically 
activated (M1-like pro-inflammatory) and alternatively activated (M2-like repair associated) 
cells were identified by colocalization of either inducible nitric oxide synthase (iNOS; M1-
like) or Arginase (Arg-1; M2-like) markers in Iba1+ cells (Fig. 7A). While ungrafted mice 
were characterized by the exclusive presence of M1-type inflammatory phenotype, both 
hOPCs and hNPCs transplants tended to reduce the percentage of Iba1+/iNOS+ M1-like cells. 
While hOPCs sustained essentially M1-like microglial cell phenotype (48.1 ± 7.4% of 
Iba1+/iNOS+ cells versus 24.8 ± 2.6% of Iba1+/Arg-1+ M2-like cells), with a low M2/M1 ratio 
(0.51 ± 0.2), hNPCs induced a substantial shift from M1-like to M2-like phenotype (M2/M1 
ratio =1.39 ± 0.12), with 35.3 ± 1.3% of Iba1+/iNOS+ and 49.0 ± 3.7% of Iba1+/Arg-1+ cells) 
(Fig. 7B). To further validate iNOS and Arginase expression levels as well as other M1-like 
(CD32, CD86, CD16) and M2-like (Tgfβ, CD206, Igf1) markers, we performed quantitative 
real-time RT-PCR on CD11b+ cells, isolated from corpus callosum of hOPCs-, hNPCs-grafted 
mice and ungrafted mice. Analysis confirmed the trend for down-regulation of iNOS in both 
hNPCs- (0.66 ± 0.22) and hOPCs-grafted mice (0.14 ± 0.06) as well as higher expression of 
arginase in hNPCs-grafted mice (26.25 ± 3.14) compared to hOPCs-grafted mice (1.34 ± 
0.67) (Fig. 7C). In parallel, the modulation of iNOS or arginase observed in hNPCs-grafted 
mice was correlated to results obtained in vitro with polarized microglia into the M1-like state 
by IFNγ, and into the M2-like phenotype by IL4 (iNOS: 0.36 ± 0.07; Arginase: 1,056.19 ± 
21.76) normalized on unpolarised microglial cells (Fig. 7D). Thus exogenous hNPCs down-
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regulated the host inflammatory context more efficiently than hOPCs by polarizing CD11b+ 
cells mainly into a repair M2-like state. 
 
Discussion  
PLP1 overexpression exerts a toxic gain-of-function resulting in oligodendrocyte death. 
Current endogenous repair strategies aim to minimize pathological effects of mutations using 
micro RNA to reduce Plp1 mRNA levels [28], or cholesterol treatment [29]. However, cell 
substitution may be another promising alternative therapy for PMD. 
 
Proof of principle for cell-based therapy for PMD was provided by transplanting rodent CNS 
tissue fragments in jimpy mice [30], a PMD model of Plp1 gene point-mutation, and was 
further confirmed by grafting purified populations of rodent glial precursor cells in myelin-
deficient (md) rats [31] or shaking pups [32]. Although these studies demonstrated that non-
affected rodent precursor cells survived and differentiated normally into oligodendrocytes in 
the PMD environment, the benefit of rodent NPCs or human NPCs/OPCs engraftment in 
these models has not been investigated. Moreover, rational progress with cell-therapy requires 
comparison of different cell types (NPCs versus OPCs) in the same experimental paradigm. 
Finally, in view of the obvious differences in biology existing between human and rodent 
cells, the efficacy of human cells in a relevant model of PMD has not been demonstrated but 
is required for appropriate clinical translation of cell therapy for PMD.  In this study, we 
addressed whether hOPCs or hNPCs are better candidates for PMD cell-based therapy, by 
comparing these two populations in parallel after engraftment into the newborn brain of a 
mouse model of severe PMD.  
Plp-tg mice were backcrossed with Rag2-/- littermates to prevent human cell rejection. 
Although previous studies have demonstrated the involvement of T-lymphocytes in myelin 
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degeneration [33] and in the perturbation of retrograde axonal transport and axonal swelling 
in Plp-tg mice [34], we did not detect significant improvement of survival, disability, 
inflammation or myelination in Plp-tg:Rag mice compared to non-Rag littermates. Cells 
grafted rostrally to the corpus callosum of newborn pups migrated progressively into all brain 
regions, with a preference for areas controlling balance and motor coordination such as corpus 
callosum and fimbria. Rotarod data showed that motor coordination and balance of hNPCs-
grafted Plp-tg:Rag mice was significantly improved compared to ungrafted Plp-tg:Rag mice 
at 25 weeks p.t., but was inferior to wild-type Rag-/- mice. Moreover, while rod fall latencies 
of Plp-tg:Rag mice decreased with time until death, that of hNPCs-grafted mice remained 
higher over time. This mild improvement might result from newly formed myelin, in areas 
involved in locomotion/balance, such as the cerebellum. Possibly, transplanting more cells or 
targeting more sites [18] might optimize cell spreading to the cerebellum, brainstem and 
spinal cord and further improve locomotor activity and survival. 
 
Several studies highlighted that transplantation of hOPCs, derived from foetal brain or from 
iPS, into immunodeficient shiverer:Rag mouse brain induced widespread myelination and 
extended lifespan of their host [17, 18]. Surprisingly, this was not the case when hOPCs were 
grafted into Plp-tg:Rag mice. In spite of the presence of extensive exogenous myelination, 
hOPCs-grafted mice died as prematurely as ungrafted mice (20 weeks). The failure of hOPCs 
to promote Plp-tg:Rag survival was not due to any potential intrinsic defect of the grafted 
hOPCs population. Indeed, these hNPCs-derived hOPCs were bonified hOPCs expressing 
OPCs markers such as PDGFRα and Olig2, as validated at the protein and transcriptional 
levels. Second, after engraftment into immunodeficient shiverer:Rag mice, grafted hOPCs 
differentiated successfully into myelin-forming cells and improved host survival, from 23 to 
30 weeks (Fig. 2J) as previously reported [17]. Additionally, their failure to improve Plp-
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tg:Rag mice survival did not result from excessive cell death since hOPCs did not express 
Caspase 3 and were present in equal densities to hNPCs after engraftment in the Plp-tg:Rag 
cerebral parenchyme. The absence of rescue of the Plp-tg:Rag phenotype in spite of 
exogenous hOPCs-derived myelination highlights the existence of a major pathological 
process, which is linked preferentially to inflammation rather than demyelination. The 
significance of the inflammatory process is reinforced by the unexpected improvement of 
hNPCs-grafted mice survival up to one year p.t., in spite of the absence of myelination at 15 
weeks p.t. This extended survival following hNPCs transplantation may result from hNPCs-
derived immunomodulation since astrocyte reactivity and microglial density were reduced at 
15 weeks p.t. Reduction of the inflammatory burden allowed the slow process of 
differentiation of hNPCs into oligodendrocytes to proceed beyond the otherwise restricted 
lifespan of their host. The observation that hNPCs and hOPCs extend survival of shiverer:Rag 
mice but that only hNPCs increase life expectancy of Plp-tg:Rag mice, suggests that a mildly 
inflammatory phenotype such as shiverer can be rescued by myelination [35] while a severe 
inflammatory PMD phenotype requires efficient immunomodulation in addition to myelin 
restoration. Moreover, the difference in survival between these two models highlights the 
limits of the shiverer model [26] and the necessity to use more relevant disease models, such 
as Plp-tg:Rag mice, to develop efficient cell therapy for PMD. 
Unlike in shiverer mice [13], hNPCs transplanted into Plp-tg:Rag animals differentiated 
predominantly into oligodendrocytes but to a minor extent into astrocytes or neurons, 
suggesting that disease-specific environments affect differentially the fate of exogenous cells. 
Therefore, it seems that therapeutic strategies using hOPCs with astrocytes or neurons cannot 
be efficient in PMD. It also highlights that the major difference in the respective therapeutic 
benefits between hNPCs and hOPCs results more from mechanisms such as modulation of 
inflammation rather than the myelination capacities of the two populations. Although hNPCs 
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required twice more time than hOPCs to generate mature oligodendrocytes, both cell types 
were equally myelinogenic, producing robust myelination in their target sites, as validated by 
immunodetection of GFP by fluorescent and electron microscopy. Moreover, hNPCs grafted 
in newborn shiverer:Rag mice differentiated along the same time frame as in Plp-tg:Rag 
mice, indicating that the PMD environment neither prevented [30] nor delayed the maturation 
of healthy exogenous cells. 
Both hNPCs and hOPCs migrated widely with a preference for white matter tracks. 
Widespread white matter colonization by the grafted cells suggests strong chemoattractive 
signalling, possibly mediated via M1-like microglial cells [36] which are present in Plp-
tg:Rag white matter. Interestingly, only hNPCs reduced microglial cell number and astrocyte 
reactivity, confirming the anti-inflammatory properties of NPCs as revealed after intravenous 
or intraparenchymal injection [21, 24, 25], and highlighting that this effect is sustained 
irrespective of the disease inflammatory context. 
The presence of hNPCs in Plp-tg:Rag mice was associated with a switch of M1-like 
microglial cells phenotype into M2-like anti-inflammatory cells phenotype, and suggests the 
release of immunomodulatory factors as observed for mouse-NPCs grafted in the injured 
spinal cord [25] or during endogenous remyelination [36]. Although iNOS transcript 
expression level was lower in hOPCs-transplanted mice than in hNPCs-grafted mice, 
microglial cells remained essentially M1-like. This presumably results from insufficiency or a 
different spectrum of secreted trophic factors and cytokines involved in M2-like polarization 
as suggested by the weak expression of arginase and other M2-like markers. Rescue of 
hNPCs-grafted Plp-tg:Rag mice could result from the modification of M1/M2 balance rather 
than the decrease of microglial cell number as observed in Krabbe’s disease [37]. Thus, the 
different response of hNPCs and hOPCs on Plp-tg:Rag mice inflammation highlights their 
respective immunomodulatory properties through their own spectrum of secreted cytokines. 
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Deciphering how hNPCs mediate the transition from M1-like to M2-like phenotype in Plp-
tg:Rag mice could lead to the identification of therapeutic molecules and further improve 
PMD cell therapy [38]. Indeed, a strategy combining pharmacological immunomodulation to 
improve recipient survival and fast and efficient myelin replacement via cell therapy to 
prevent axon dysfunction would appear as an optimal therapeutic treatment for PMD and 
possibly other inflammatory demyelinating disorders. Indeed, although this study highlights 
the benefit of hNPCs transplantation in a severe PMD model, the optimal strategy could be to 
accelerate the generation of myelin to protect axons using hOPCs in combination with the use 
of immunomodulatory drugs to reduce the deleterious effect of inflammation. One could 
question the relevance of our data on microglia phenotype in PMD. Indeed, very few 
histopathological studies reported inflammation in PMD and none of them described 
microglial polarization. Although, recent data indicated microglial activation in a variety of 
PMD patients, including those affected with PLP1 duplication [5], histopathological data are 
insufficient to infer whether inflammation precedes or results from demyelination. In the latter 
case, it could aggravate PMD physiopathology. Interestingly and even more relevant to the 
human disease is the effect of hNPCs on astrocytosis which is commonly described in PMD 
[39]. As astrocytes and microglia may be activated by each other [40-42], it remains plausible 
that the observed effects on microglia are mediated via astrocytes or vice-versa. 
 
Conclusion 
In summary, we provide the first evidence that immunomodulation, myelin repair and clinical 
improvement can be successfully achieved by hNPCs cell therapy in a model of severe PMD. 
Our work highlights the major role of neuroinflammation (microglial activation and 
astrocytosis) in disease severity and the link between successful modulation of this parameter 
and Plp-tg_Rag mice lifespan. Finally and unexpectedly, we found that exogenous hNPCs 
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restrained more efficiently the severe murine PMD phenotype by providing first 
immunomodulation and second myelin repair. Although future studies should elucidate the 
molecular and cellular events underlying down-regulation of neuroinflammation and 
neuroprotection provided by hNPCs in experimental PMD, our present findings may pave the 
way to optimize cell-based therapies for myelin disorders associated with progressive 
inflammation.  
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Figure Legends:  
Figure 1. Characterization of adult Plp-tg:Rag mice.  
Hypomyelination of homozygous Plp-tg:Rag mice compared to wild-type mice is revealed by 
electron microscopy (A), MRI scans (B), and immunohistochemistry for MBP (red) (C, C’). 
Astrocytosis (D, D’) and microglial activation (E, E’) are detected respectively by GFAP 
(red) and Iba1 (red) immunolabeling (n=3 per group). Nuclei are counterstained by Dapi 
(blue). cc: corpus callosum; f: fimbria; v: lateral ventricle. Scale bars: (A) 1 µm; (C-E) 100 
µm; (C’-E’) 500 µm. 
 
Figure 2. Phenotype of CD140a sorted cells.  
Both CD140a-PE positive and negative fraction were characterized 24hrs after sorting. The 
positive fraction expressed (A) the OPC marker PDGFR alpha, (B) the oligodendroglial 
lineage transcription factor Olig2 and (C) the proliferation marker Ki67. The negative fraction 
did not express (D) PDGFR alpha or (E) Olig2. (F) Most of this population was neuronal, 
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expressing TuJI. Scale bars: 50 µm. (G) Quantitative RT-PCR highlighted gene set 
enrichment of both positive (green) and negative (red) fractions. Data (n = 4) are presented as 
values of total cell population before sorting after normalization with Cyclophilin A levels. 
(H-I) Horizontal sections through the corpus callosum of a 15 week old shiverer:Rag mice 
demonstrated that (H) CD140a-sorted hOPCs myelinate more effectively than (I) hNPCs. (J) 
Shiverer:Rag mice transplanted with CD140a-sorted hOPCs survived up to 30 weeks. MBP is 
stained in red, GFP+ cells are in green. Dapi+ nuclei are in blue. Scale bars: (H-J) 800 µm; 
(H’-J’) 200 µm. 
 
Figure 3. hNPCs grafted mice exhibit increased lifespan and locomotor improvement. 
(A) Kaplan-Meier survival graph and (B) histogram showing the percentage of hNPCs- 
(n=27), hOPCs-grafted mice (n=11) and ungrafted (Ug) mice surviving (n=76) with age. (+) 
corresponds to mice sacrificed for immunochemistry or electron microscopy. (C) Latency to 
fall (sec) monitored by accelerating rotarod assay. Rag2-/- mice were used for controls (n=6). 
Results are the mean of three consecutive tests. The curves of hOPCs-grafted mice and 
ungrafted mice stop respectively at 15 and 30 weeks p.t. because of their premature death.  
Error bars indicate ± SEM. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups 
using Student’s t test. 
 
Figure 4. hNPCs and hOPCs give rise to mature oligodendrocytes after transplantation 
into the corpus callosum of Plp-tg:Rag mice. 
Double immunohistochemical labeling for GFP (green) and human specific NOGO-A (red) 
(A) or APC (red) (B) reveal differentiation of hOPCs (n=3) and hNPCs (15 weeks: n=3; 30 
weeks: n=4) into mature oligodendrocytes in Plp-tg:Rag mice (arrows). Nuclei are 
counterstained by Dapi (blue). Scale bars represent 50 µm. (C) Quantification of the 
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percentage of APC+ or NOGO-A+ cells on the total number of GFP+ cells. Data are shown as 
mean ± SEM. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups using Student’s t 
test. 
 
Figure 5. hOPCs and hNPCs produce myelin and restore nodes of Ranvier after 
transplantation in Plp-tg:Rag mice. 
(A, B) Horizontal sections through the corpus callosum illustrating substantial remyelination 
by hOPCs at 15 weeks (A) and hNPCs at 30 weeks (B). (C) Quantification of myelin 
corresponds to the percentage of MBP labelled area of the corpus callosum. (ungrafted: n=3; 
hOPCs: n=3; hNPCs: 15 weeks n=5; 30 weeks n=3). Data are shown as mean ± SEM. (D) 
Orthogonal projection of hNPCs in contact with myelin internodes (arrows) and (E) presence 
of Bluo-gal precipitates in myelin sheaths enwrapping axons demonstrate donor-derived 
myelination. MBP is stained in red, GFP+ cells are in green. Dapi+ nuclei are in blue. (F) 
Nodal reconstitution by hOPCs and hNPCs-derived oligodendrocytes is revealed by 
immunostaining of paranodal Caspr (red) and nodal Neurofascin (green) proteins. (G) 
Involvement of both type of grafted cells in nodal reconstitution is reported by 
immunostaining of paranodal Caspr (red) and GFP (green) proteins. Dapi+ nuclei are in blue.  
Lower panels in (A) and (B) are higher magnifications of top panels. cc: corpus callosum; f: 
fimbria; v: lateral ventricle. Scale bars: (A-B) 100 µm higher panel, 25 µm lower panel; (D) 
500 µm; (E) 200 nm; (F-G) 5 µm. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated 
groups using Student’s t test. 
 
Figure 6. Human hNPCs down-regulate microglia and astrocyte loads. 
(A, B) Microglial cells (A) and astrocytes (B) load at 15 weeks p.t. Microglial cells (Iba1) and 
astrocytes (GFAP) are stained in red while human cells (GFP) are in green, Dapi+ nuclei are 
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in blue. Lower panels of (A) and (B) are higher magnifications of top panels. Scale bars: 100 
µm higher panel, 25 µm lower panel. (C, D) Quantification of microglia (C) and astrocyte (D) 
densities are expressed as the percentage of Iba1 and GFAP labelled areas of the corpus 
callosum (ungrafted: n=3; hOPCs: n=3; hNPCs: n=9). Data are shown as mean ± SEM. *p < 
0.05; **p<0.01; ***p<0.001 versus the indicated groups using Student’s t test. 
 
Figure 7. Human hNPCs induce a M2-like microglial phenotype. 
(A) M1-like and M2-like microglia activation state are revealed by colocalization of Iba1+ 
cells (green) with iNOS or Arginase-1 (red) respectively. Dapi+ nuclei are in blue. The flat 
morphology in the ungrafted and hOPCs-grafted mice correlates with the iNOS+ M1-like 
activated state while the bipolar morphology of microglia in hNPCs-grafted mice correlates 
with the Arginase-1 M2-like state (ungrafted: n=3; hOPCs: n=3; hNPCs: n=9). Scale bars 
represent 50 µm. (B) Ratio of the percentage of Iba1+/Arg-1+ cells (M2-like) to the percentage 
of Iba1+/iNOS+ cells (M1-like). (C-D) Quantitative real-time RT-PCR highlighted modulation 
of classically activated M1-like and alternatively activated M2-like gene expression of (C) 
CD11b+ cells isolated from hNPCs- and hOPCs-grafted mice versus CD11b+ cells from 
ungrafted mice, and of (D) in vitro IL-4-atcivated or IFNγ-activated microglial cell versus 
unactivated microglia. Data are presented as values of relative gene expression after 
normalization with GAPDH levels. Data are shown as mean ± SEM. *p < 0.05; **p<0.01; 
***p<0.001 versus the indicated groups using Student’s t test. 
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Figure 1. Characterization of adult Plp-tg:Rag mice.  
Hypomyelination of homozygous Plp-tg:Rag mice compared to wild-type mice is revealed by electron 
microscopy (A), MRI scans (B), and immunohistochemistry for MBP (red) (C, C’). Astrocytosis (D, D’) and 
microglial activation (E, E’) are detected respectively by GFAP (red) and Iba1 (red) immunolabeling (n=3 
per group). Nuclei are counterstained by Dapi (blue). cc: corpus callosum; f: fimbria; v: lateral ventricle. 
Scale bars: (A) 1 µm; (C-E) 100 µm; (C’-E’) 500 µm.  
128x126mm (300 x 300 DPI)  
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Figure 2. Phenotype of CD140a sorted cells.  
24hrs after sorting, both CD140a-PE positive and negative fraction were characterized. Positive fraction 
expressed (A) the OPC marker PDGFR alpha, (B) the oligodendroglial lineage transcription factor Olig2 and 
(C) the proliferation marker Ki67. Negative fraction did not express (D) PDGFR alpha or (E) Olig2. (F) Most 
of this population was neuronal, expressing TuJI. Scale bars: 50 µm. (G) Quantitative real-time RT-PCR 
highlighted gene set enrichment of both positive (green) and negative (red) fraction. Data (n = 4) are 
presented as values of total cell population before sorting after normalization with Cyclophilin A levels. (H-I) 
Horizontal sections through the corpus callosum of a 15 week old shiverer:Rag mice demonstrated that (H) 
CD140a-sorted hOPCs myelinate more effectively than (I) hNPCs. (J) Shiverer:Rag mice transplanted with 
CD140a-sorted hOPCs survived up to 30 weeks. MBP is stained in red, GFP+ cells are in green. Dapi+ nuclei 
are in blue. Scale bars: (H-J) 800 µm; (H’-J’) 200 µm.  
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Figure 3. hNPCs grafted mice exhibit increased lifespan and locomotor improvement.  
(A) Kaplan-Meier survival graph and (B) histogram showing the percentage of hNPCs- (n=27), hOPCs-
grafted mice (n=11) and ungrafted (Ug) mice surviving (n=76) with age. (+) corresponds to mice sacrificed 
for immunochemistry or electron microscopy. (C) Latency to fall (sec) monitored by accelerating rotarod 
assay. Rag2-/- mice were used for controls (n=6). Results are the mean of three consecutive tests. The 
curves of hOPCs-grafted mice and ungrafted mice stop respectively at 15 and 30 weeks p.t. because of their 
premature death.  Error bars indicate ± SEM. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated 
groups using Student’s t test.  
80x84mm (300 x 300 DPI)  
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Figure 4. hNPCs and hOPCs give rise to mature oligodendrocytes after transplantation into the corpus 
callosum of Plp-tg:Rag mice.  
Double immunohistochemical labeling for GFP (green) and human specific NOGO-A (red) (A) or APC (red) 
(B) reveal differentiation of hOPCs (n=3) and hNPCs (15 weeks: n=3; 30 weeks: n=4) into mature 
oligodendrocytes in Plp-tg:Rag mice (arrows). Nuclei are counterstained by Dapi (blue). Scale bars represent 
50 µm. (C) Quantification of the percentage of APC+ or NOGO-A+ cells on the total number of GFP+ cells. 
Data are shown as mean ± SEM. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups using 
Student’s t test.  
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Figure 5. hOPCs and hNPCs produce myelin and restore nodes of Ranvier after transplantation in Plp-tg:Rag 
mice.  
(A, B) Horizontal sections through the corpus callosum illustrating substantial remyelination by hOPCs at 15 
weeks (A) and hNPCs at 30 weeks (B). (C) Quantification of myelin corresponds to the percentage of MBP 
labelled area of the corpus callosum. (ungrafted: n=3; hOPCs: n=3; hNPCs: 15 weeks n=5; 30 weeks n=3). 
Data are shown as mean ± SEM. (D) Orthogonal projection of hNPCs in contact with myelin internodes 
(arrows) and (E) presence of Bluo-gal precipitates in myelin sheaths enwrapping axons demonstrate donor-
derived myelination. MBP is stained in red, GFP+ cells are in green. Dapi+ nuclei are in blue. (F) Nodal 
reconstitution by hOPCs and hNPCs-derived oligodendrocytes is revealed by immunostaining of paranodal 
Caspr (red) and nodal Neurofascin (green) proteins. (G) Involvement of both type of grafted cells in nodal 
reconstitution is reported by immunostaining of paranodal Caspr (red) and GFP (green) proteins. Dapi+ 
nuclei are in blue.  Lower panels in (A) and (B) are higher magnifications of top panels. cc: corpus callosum; 
f: fimbria; v: lateral ventricle. Scale bars: (A-B) 100 µm higher panel, 25 µm lower panel; (D) 500 µm; (E) 
200 nm; (F-G) 5 µm. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups using Student’s t test. 
169x144mm (300 x 300 DPI)  
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Figure 6. Human hNPCs down-regulate microglia and astrocyte loads.  
(A, B) Microglial cells (A) and astrocytes (B) load at 15 weeks p.t. Microglial cells (Iba1) and astrocytes 
(GFAP) are stained in red while human cells (GFP) are in green, Dapi+ nuclei are in blue. Lower panels of 
(A) and (B) are higher magnifications of top panels. Scale bars: 100 µm higher panel, 25 µm lower panel. 
(C, D) Quantification of microglia (C) and astrocytes (D) densities are expressed as the percentage of Iba1 
and GFAP labelled areas of the corpus callosum (ungrafted: n=3; hOPCs: n=3; hNPCs: n=9). Data are 
shown as mean ± SEM. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups using Student’s t 
test.  
169x98mm (300 x 300 DPI)  
 
 
Page 40 of 43
ScholarOne Support: (434) 964-4100
Stem Cells
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 7. Human hNPCs induce a M2-like microglial phenotype.  
(A) M1-like and M2-like microglia activation state are revealed by colocalization of Iba1+ cells (green) with 
iNOS or Arginase-1 (red) respectively. Dapi+ nuclei are in blue. The flat morphology in the ungrafted and 
hOPCs-grafted mice correlates with the iNOS+ M1-like activated state while the bipolar morphology of 
microglia in hNPCs-grafted mice correlates with the Arginase-1 M2-like state (ungrafted: n=3; hOPCs: n=3; 
hNPCs: n=9). Scale bars represent 50 µm. (B) Ratio of the percentage of Iba1+/Arg-1+ cells (M2-like) to 
the percentage of Iba1+/iNOS+ cells (M1-like). (C-D) Quantitative real-time RT-PCR highlighted modulation 
of classically activated M1-like and alternatively activated M2-like gene expression of (C) CD11b+ cells 
isolated from hNPCs- and hOPCs-grafted mice versus CD11b+ cells from ungrafted mice, and of (D) in vitro 
IL-4-atcivated or IFNγ-activated microglial cell versus unactivated microglia. Data are presented as values of 
relative gene expression after normalization with GAPDH levels. Data are shown as mean ± SEM. *p < 0.05; 
**p<0.01; ***p<0.001 versus the indicated groups using Student’s t test.  
168x151mm (300 x 300 DPI)  
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Supplemental Data 
Figure Legends:  
Supplemental Figure 1. Human NPCs and OPCs survive and migrate extensively in Plp-
tg:Rag white matter areas. 
(A) Widespread distribution of hNPCs and hOPCs throughout their host brain as viewed at 
different levels of transversal brain sections at 15 weeks p.t. (B) Quantification of hNPCs and 
hOPCs in the corpus callosum at 15 weeks post transplantation (n=3 per group). Error bars 
indicate ± SEM. (C) Preferential migration of human cells (hNPCs) in white matter areas: (i) 
corpus callosum, (ii) fimbria, (iii) cerebellum, (iv) striatum, (v) anterior commissure, (vi) and 
olfactory bulbs at 35 weeks p.t. (n=3). Scale bars: (A) 1 mm; (C) 100 µm. *p < 0.05; 
**p<0.01; ***p<0.001 versus the indicated groups using Student’s t test. 
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Supplementary Figure S1. Human NPCs and OPCs survive and migrate extensively in Plp-tg:Rag white 
matter areas.  
(A) Widespread distribution of hNPCs and hOPCs throughout their host brain as viewed at different levels of 
transversal brain sections at 15 weeks p.t. (B) Quantification of hNPCs and hOPCs in the corpus callosum at 
15 weeks post transplantation (n=3 per group). Error bars indicate ± SEM. (C) Preferential migration of 
human cells (hNPCs) in white matter areas: (i) corpus callosum, (ii) fimbria, (iii) cerebellum, (iv) striatum, 
(v) anterior commissure, (vi) and olfactory bulbs at 35 weeks p.t. (n=3). Scale bars: (A) 1 mm; (C) 100 
µm. *p < 0.05; **p<0.01; ***p<0.001 versus the indicated groups using Student’s t test.  
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